Immediate Impact
1 by Nobel laureates 51 standout
Citing Papers
mRNA vaccines for infectious diseases — advances, challenges and opportunities
2024 Standout
Bispecific and multispecific antibodies in oncology: opportunities and challenges
2024 Standout
Works of Ami Aoki being referenced
MA21.05 Phase II Trial of the Combination of Alectinib with Bevacizumab in ALK-Positive Nonsquamous Non-Small Cell Lung Cancer
2019
CD103hi Treg cells constrain lung fibrosis induced by CD103lo tissue-resident pathogenic CD4 T cells
2019
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Ami Aoki | 111 | 149 | 195 | 34 | 475 | |
| Yusuke Shikama | 109 | 79 | 125 | 25 | 429 | |
| R.L. Dawkins | 57 | 78 | 291 | 36 | 571 | |
| A. Saussine | 65 | 118 | 223 | 23 | 490 | |
| Ikkou Higashimoto | 176 | 151 | 84 | 41 | 458 | |
| Guglielmo Bruno | 57 | 134 | 199 | 35 | 493 | |
| N.H. Cox | 46 | 164 | 133 | 27 | 539 | |
| Motoko Yasutomi | 80 | 84 | 216 | 40 | 573 | |
| James W. Swann | 58 | 86 | 247 | 29 | 562 | |
| Shinyu Izumi | 115 | 111 | 186 | 25 | 567 | |
| Ömür Ardeniz | 105 | 71 | 282 | 28 | 504 |
All Works
Login with ORCID to disown or claim papers
Loading papers...